Moderna Inc. Stock Advances 14.2%, Outperforms Peers

Dow Jones2026/10/09 20:32

This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Moderna Inc. jumped 14.2% to $225.00 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.6% to 27,366.17 and the Dow Jones Industrial Average rising 0.8% to 51,654.95. This was the stock's third consecutive day of gains. Moderna Inc. hit a new 52-week high, surpassing its previous peak of $212.22, which the company achieved on October 6th. The stock outperformed some of its peers, as Johnson & Johnson rose 1.9% to $261.44, Pfizer Inc. rose 1.7% to $28.28, and Gilead Sciences Inc. rose 2.77% to $151.17. Trading volume totaled 28.7 million, compared to the 50-day average of 21.5 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 09, 2026 16:32 ET (20:32 GMT)

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.